beta2-Microglobulin in lymphoproliferative disorders with special reference to gammapathies

Area of Science:

• Biochemistry
• Hematology
• Oncology

Background:

• Beta2-microglobulin (B2M) is a protein found on the surface of most nucleated cells.
• Elevated B2M levels can indicate cell turnover or proliferation.
• Lymphoproliferative disorders involve the abnormal proliferation of lymphocytes.

Purpose of the Study:

• To investigate the utility of the plasma beta2-microglobulin to serum creatinine ratio as a biomarker.
• To assess the relationship between this ratio and tumor burden in lymphoproliferative disorders.

Main Methods:

• Calculation of the plasma beta2-microglobulin to serum creatinine ratio.
• Analysis of ratio levels in patients with various lymphoproliferative disorders.
• Correlation analysis between the ratio and tumor mass.

Main Results:

• The plasma beta2-microglobulin to serum creatinine ratio was found to be elevated in patients with lymphoproliferative disorders.
• A positive correlation was observed between the degree of ratio elevation and tumor mass.
• This suggests the ratio reflects disease activity and tumor burden.

Conclusions:

• The adjusted plasma beta2-microglobulin ratio serves as a potential indicator for lymphoproliferative disorders.
• The ratio's direct proportionality to tumor mass highlights its value in assessing disease severity.
• Further research can explore its prognostic and diagnostic capabilities.